-
- Reimbursement Consulting, Healthcare Business Solutions
- Healthcare Market Research
- Healthcare Education, Healthcare Education And Training
- Hotline Assessments and Patient Assistance Programs
- Expanded Access Program
- Case Studies
- Market Research - Leveraging insight from Payors
- Comparative Cost Analysis - Pharmaceuticals
- Healthcare Reform Analysis
- Health Technology Assessment - Oncology
- Reimbursement Call Center and Patient Assistance Program Design - Multiple Product Classes
- Comparative Effectiveness Review - Diabetes
- Reimbursement Training and Field Reimbursement Call Tracking Tool
- Competitive Intelligence - Urology
- Product Commercialization and Reimbursement Landscape Analysis - Oncology
- Clinical Services Evaluation - Specialty Pharmacy
- Commercialization Strategy - Deep Vein Thrombosis
- Coverage Analysis - Drug Delivery System
- Reimbursement Coverage and Coding Analysis - Vascular Stents
- Health Economic Analysis - Rheumatoid Arthritis
- Health Economics Analysis - Diabetes Mellitus Blood Glucose Monitoring
- Expanded Access
- Comprehensive Clinical Analysis and Clinical Protocol Design - Migrane
- Outcomes Research Plan - Gastroenterology
- Clinical Compendium and Gap Analysis - Pain Management
- Reimbursement Landscape Analysis - Rare Bleeding Disorders (Hemophilia)
- Disease Area Review and Burden of Illness Analysis - Oncology
- Hospital Inpatient Payor Claims Analysis - Hospital Acquired Infections
- Health Economic Analysis - Orthopedics
- Market Valuation - Opioids
- Meta Analysis - HIV (Human Immunodeficiency Virus)
- AMCP Dossier - Dermatology
- Competitive Intelligence - Infectious Diseases
- Competitive Intelligence - Contraception
- Reimbursement Landscape Analysis - Urology
- Health Economics Analysis - Crohn's Disease
- Comprehensive Reimbursement and Health Economic Analysis - Neurovascular Disease
- Patient Assistance Program Design - Insulin Products
- Health Technology Assessment - Wound Therapy System
Case Studies
Patient Assistance Program Design - Insulin Products
Insight
A global leader in dialysis products wanted to explore possible programs that could be developed to encourage greater interest in the client’s product and involve the distribution of the product, separate from patient assistance programs.Strategy
The Aequitas Group was asked to assess the appropriateness of possible program scenarios that were being considered by the client and provide them with an assessment of the liabilities, risks and cures for these programs, with the goal of steering any program that might be implemented by them towards compliance with the legal advisories as articulated by the Health and Human Services (HHS) Office of Inspector General (OIG).Execution
A review of laws and regulations specific to drug distribution assistance to patients (not including patient assistance programs) was performed by a licensed attorney at The Aequitas Group, and provided the client with a summary of applicable laws and regulations, identified key statutes that had been interpreted broadly by various pharmaceutical companies, and helped develop a risk assessment the client could use to inform the internal decision.© 2009 The Aequitas Group, Inc. All Rights Reserved.